Orexo AB (ORXOY: OTCQX International) | Orexo receives million 5£ milestone payment for Abstral® in Europe and Zubsolv® continues strong market share growth in the US

Orexo receives million 5£ milestone payment for Abstral® in Europe and Zubsolv® continues strong market share growth in the US

Dec 17, 2014

OTC Disclosure News Service

Stockholm, Uppsala, Sweden

This release includes additional documents. Select the link(s) below to view.

2014-12-17.pdf

Copyright © 2014 OTC Markets. All Rights Reserved

The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.

Article source: http://www.otcmarkets.com/stock/ORXOY/news?id=93863

Leave a Reply

WP2Social Auto Publish Powered By : XYZScripts.com
Bunk Beds